Harbor Capital Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,683
Closed -$209K 1446
2024
Q4
$209K Sell
2,683
-1,718
-39% -$127K 0.01% 653
2024
Q3
$295K Sell
4,401
-11,301
-72% -$928K 0.01% 636
2024
Q2
$1.78M Buy
15,702
+1,812
+13% +$229K 0.14% 231
2024
Q1
$1.93M Sell
13,890
-506
-4% -$63.6K 0.25% 86
2023
Q4
$1.79M Buy
14,396
+821
+6% +$83.9K 0.34% 76
2023
Q3
$1.27M Buy
13,575
+2,134
+19% +$241K 0.27% 94
2023
Q2
$1.47M Sell
11,441
-4,255
-27% -$515K 0.29% 87
2023
Q1
$1.82M Buy
15,696
+6,874
+78% +$769K 0.53% 53
2022
Q4
$999K Sell
8,822
-190
-2% -$20.9K 0.97% 36
2022
Q3
$726K Sell
9,012
-996
-10% -$84.4K 0.67% 49
2022
Q2
$746K Sell
10,008
-316
-3% -$28.8K 0.57% 58
2022
Q1
$1.32M Buy
10,324
+228
+2% +$24.9K 0.62% 50
2021
Q4
$1.35M Buy
+10,096
New +$1.45M 0.49% 59

Other funds holding DXCM

Harbor Capital Advisors's DXCM Position: Q1 2025 in Review

Harbor Capital Advisors sold out of DexCom (DXCM) in Q1 2025, closing a stake of 2,683 shares — an estimated $209K sold.

Harbor Capital Advisors first reported a position in DXCM in Q4 2021 and held it in 13 quarters. The position peaked at $1.93M in Q1 2024. 932 funds tracked by Wall St. Rank hold DXCM as of Q1 2025.

  • Harbor Capital Advisors reported no remaining DexCom position as of Q1 2025 after selling out during the quarter.
  • Harbor Capital Advisors sold 2,683 DexCom shares in Q1 2025, an estimated $209K.
  • Harbor Capital Advisors first reported a position in DexCom in Q4 2021 and held it in 13 quarters.
  • Harbor Capital Advisors's DexCom position peaked at $1.93M in Q1 2024.
  • 932 funds tracked by Wall St. Rank held DexCom as of Q1 2025.

Based on Harbor Capital Advisors's 13F filing for Q1 2025, filed 14 Apr 2025.